All in on IL-11, Fra­zier un­veils lat­est start­up with dual fo­cus on fi­bro­sis and can­cer

In late 2017, a team of Sin­ga­pore­an sci­en­tists pub­lished a Na­ture pa­per high­light­ing what they call a “ground­break­ing” and out­stand­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.